Fasinumab (Anti-NGF / bNGF)
Fasinumab (Anti-NGF / bNGF) (A3008-GRP)
Products
Description
Fasinumab (Anti-NGF / bNGF) is a human IgG1k monoclonal antibody targeting nerve growth factor (NGF). It can be used in acute sciatica and knee osteoarthritis (OA) studies. MW :144.9 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A3008 |